Combining the oral drug ixazomib and lower-dose lenalidomide shows important reductions in neutropenia and peripheral neuropathy in transplant-ineligible, newly diagnosed multiple myeloma.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/multiple-myeloma-novel-quad-regimen-eases-toxicity-2025a1000phm?src=rss
Author :
Publish date : 2025-09-24 09:48:00
Copyright for syndicated content belongs to the linked Source.
